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A transaminase from Halomonas elongata and four mutants generated by an in silico-based design, were recombinantly produced 
in E. coli, purified and applied to the amination of mono-substituted aromatic carbonyl-derivatives. While benzaldehyde 
derivatives resulted excellent substrates, only NO2-acetophenones were transformed into the (S)-amine with high 
enantioselectivity. The different behaviour of wild-type and mutated transaminases was assessed by in silico substrate binding 
mode studies.  
Introduction 
The remarkable work of Codexis-Merck in evolving an amino transferase to achieve a “greener” synthesis of Sitaglipin,1 highlighted 
the promising features of this class of enzymes as biocatalytic tool for the manufacturing of chiral amines,2 valuable building blocks 
for a wide range of bioactive compounds.3,4 The
mechanism underlying -transaminase activity has been generally assumed similar to that of aspartate transaminase;5,6 only recently 
the reaction mechanism of Chromobacterium violaceum ω-transaminase has been investigated by means of density functional theory 
calculations and the energy profile for the conversion of (S)-1-phenylethylamine to acetophenone has been calculated. In this study 
the involved transition states and intermediates have been characterised.7 The first step in the conversion of carbonyls into amines 
involves the nucleophilic attack from the amino donor intermediate pyridoxamine-5'-phosphate (PMP) to the amino acceptor 
carbonyl group.7 The stereoelectronic features of the substrate play a crucial role; in the case of ketones, especially aromatic ones, 
the carbonyl carbon is often not sufficiently electrophilic and the reaction is slow and thermodynamically unfavoured.8 This aspect 
heavily influences the wide applicability of these enzymes as an alternative to conventional synthesis.9 On the other hand, 
unfavourable steric interactions between the enzyme and the substrate may hamper the reactivity and can only be gauged after 
investigation of the enzyme-substrate binding mode.10 Beside stereoelectronic effects involved in the enzymatic interactions, water 
solubility of hydrophobic substrates may also strongly influence the reactivity.  
Therefore, in attempt to characterise the electronic behaviour of the amino transferase from Halomonas elongata (HEWT),11 we 
investigated the role of different substituents on aromatic ketones, aldehydes, and the corresponding (S)-amines. The effect on the 
catalytic efficiency of the wild-type enzyme was initially studied with different mono-substituted acetophenones, having both 
electron withdrawing and donating groups (Table 1, column 3), where L-alanine was used as amino donor. Wild-type HEWT generally 
resulted poorly active, showing significant conversions only with meta- and para-nitroacetophenones. The reasons for this limited 
reactivity can be related to unfavourable electronic effects for substrates with EDG groups, whereas only strong EWG groups allowed 
significant yields by favouring the reactivity of the amine of PMP towards the carbonyl group (Fig. 1). The absence of reactivity 
towards ortho-nitroacetophenone can be ascribed to steric effects, as previously reported for the lack of activity towards these 
substrates with the yeast P. glucozyma ketoreductase KRED1-Pglu.12 
 
 
 
 
 
Fig. 1 Representation of the electronic density with EWG and EDG substituted molecules.  
 
Results and discussion  
An in silico model of the HEWT was generated to aid with the design of key mutations,13specifically introduced to probe the steric 
effect of the substituents. The three-dimensional structure was simulated on the resolved structure of the homologs amino 
transaminase from Cromobacterium violaceum.14 Due to the medium-high homology between the two proteins (56%), the built 
model was deemed reliable providing a quality standard score (Z score < 2.5) and it allowed for an accurate evaluation of the catalytic 
pocket.15 The enzyme topology for this class of enzymes has been well elucidated and it can be easily described by two pockets 
  
surrounding the cofactor pyridoxal phosphate (PLP).16,17 The large one accepts bulky groups such as aromatic rings, while the second, 
smaller one, accommodates short hydrophobic groups. 
Ortho- meta- and para-nitroacetophenones were selected to map in-silico the active site of HEWT (Fig. 2). The steric bulk of the nitro 
group, when positioned in ortho and meta, appeared to interfere with tryptophan 56 and tyrosine 149 in the large pocket, as well as 
with phenylalanine 84 which is located between the two pockets; (Fig 2 A-B). On the other hand, the para position is less hindered 
and the model predicts major interference only with W56 positioned deep into the pocket (Fig.2 C).  
 
 
 
 
Fig. 2 Model of the catalytic site of HEWT with ortho- meta- and para-nitroacetophenone. 
 
 
 
 
 
 
Entry Substrate WT ee % W56G  ee % Y149F  ee % F84A ee % I258A  ee % 
1a Acetophenone 5.0 ± 0.4 >99 6.0 ± 0.1 >99 < 5  5.0 ± 0.3 >99 5.0 ± 0.4 >99 
1b p-NO2 19.6 ± 0.2 >99 15.7 ± 0.5 96 14.2 ± 1.2 97 12.4 ± 0.5 95 19.1 ± 0.9 >99 
1c m-NO2 10.2 ±  0.8 >99 10.7 ± 0.7 95 7.3 ± 0.5 97 6.2 ± 0.6 96 8.6 ± 0.2 95 
1d o-NO2 < 5  15.9 ± 1.6 98 < 5  < 5  < 5  
1e p-F < 5  < 5  < 5  < 5  < 5  
1f m-F < 5  < 5  < 5  < 5  < 5  
1g o-F < 5  <5  < 5  < 5  < 5  
1h p-CF3 < 5  < 5  < 5  < 5  < 5  
1i m-CF3 < 5  < 5  < 5  < 5  < 5  
1j o-CF3 < 5  < 5  < 5  < 5  < 5  
1k p-OCH3 < 5  < 5  < 5  < 5  < 5  
1l m-OCH3 < 5  < 5  < 5  < 5  < 5  
1m o-OCH3 < 5  < 5  < 5  < 5  < 5  
1n p-CH3 < 5  < 5  < 5  < 5  < 5  
1o m-CH3 < 5  < 5  < 5  < 5  < 5  
1p o-CH3 < 5  < 5  < 5  < 5  < 5  
Table 1. Molar conversions of ammination of mono-substituted acetophenones 1a-p (10 mM) with transaminases (0.1 mg/mL) in phosfate buffer 
medium 50 mM pH 8,  DMSO 10% as cosolvent, 1 M L-Alanine and 0.1 mM PLP. Biotransformations were carried out for 24 h at 37°C under gently 
agitation.  
An in silico mutagenesis approach was used to evaluate optimal substitutions.18 W56G on the large pocket, and F84A near the small 
one, yielded a lower docking energy favouring the substrates accommodation with a greater effect on the ortho- substitution (ESI, 
Table S.2); Y149A also was indicative of a better docking, however this amino acid is involved in PLP stacking, therefore a more 
  
conservative substitution (Y149F) was selected. Finally, I258 appeared to be critical for enlarging the pocket; it is spatially near W56 
and prevents its side chain to rotate. A I258A mutation will allow a higher rotational flexibility to the tryptophan ring leaving more 
space for the substrate to dock (Fig. 3). Notably, the selected amino acids are highly conserved among this class of amino 
transaminase (96% among 487 protein sequences aligned and Y149 is 100% retained).19  
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3. Simulation of tryptophan rotation after the substitution of   
isoleucine 258 with alanine. 
 
The four generated mutants of HEWT were thus investigated with para- meta- and ortho- mono-substituted acetophenones as amino 
acceptor (Tab. 1, columns 4-7). The biotransformations were performed over 24 hours and under the reaction conditions selected; 
the only substrates transformed were the NO2-acetophenones (entry 1b-d).  
 
 
 
 
The enantioselectivity was also monitored validating that both the WT and the mutants selectively produced the (S)-amines, 
confirming that the mutations did not affect the stereo-preference of the catalyst. The W56G variant is the only one able to transform 
the ortho-nitroderivative. In fact, the replacement of tryptophan with glycine reduced hindrance and facilitated substrate binding 
(Fig 2 A). Due to the low reactivity of acetophenones, the same study was performed on more reactive mono-substituted 
benzaldehydes (Tab 2, entry 2a-p), using L-alanine as amino donor. As predicted by the molecular modelling, the substitution of bulky 
amino acids such as W56 and F84 with glycine and alanine respectively, and the replacement of Y149 with phenylalanine (lacking the 
OH group fundamental for steric and electronic interaction with the substrate), gave an enhanced molar conversion for all the ortho-
substituted aldehydes into the corresponding primary amines with respect to the wild type transaminase. However, in the case of 
meta-derivatives the activity of the different transaminases was predominantly dependent on substituent bulk and/or hydrophobicity 
whereas the electronic properties had negligible effects. For para-substituted aldehydes, I258A was the best variant both with EWG 
and EDG, as steric effects at this position prevailed on the electronic ones; mutating I258 allowed for greater flexibility of the 
neighbouring W56 side chain substantially increasing the size of the active site. The direct mutation of W56 with glycine yielded very 
similar results with respect to the wild type, highlighting the role of this amino acid in stabilising the para-substituents. A number of 
chiral amines with different substitution patterns on the aromatic ring have also been included in this study (Tab 3, entry 3a-h) using 
as amino acceptor sodium pyruvate. Amines are generally better accepted substrates than the corresponding ketones, and steric 
rather than electronic effects can easily be identified. 
Entry Substrate WT W56G  Y149F  F84A  I258A  
2a Benzaldehyde 22.2 ± 1.9 31.6 ± 0.8 32.0 ± 0.9 27.3 ± 0.9 22.5 ± 0.7 
2b p-NO2 72.4 ± 3.2 70.2 ± 1.0 59.3 ± 0.9 56.5 ± 1.1 80.5 ± 1.0 
2c m-NO2 65.4 ± 1.3 68.4 ± 1.1 57.0 ± 0.8 51.0 ± 1.9 50.6 ± 1.2 
2d o-NO2 69.2 ± 1.2 89.3 ± 1.1 88.8 ± 1.2 80.6 ± 0.4 64.8 ± 1.5 
2e p-F 26.2 ± 1.5 35.4 ± 1.1 23.7 ± 0.7 24.7 ± 0.3 52.0 ± 1.3 
2f m-F 64.6 ± 3.9 79.2 ± 1.3 80.0 ± 0.7 76.2 ± 1.0 65.3 ± 1.0 
2g o-F 67.9 ± 1.5 91.2 ± 1.4 96.1 ± 1.8 94.1 ± 1.0 90.6 ± 0.7 
2h p-CF3 70.8 ± 2.7 67.0 ± 0.8 74.5 ± 0.6 72.9 ± 0.6 97.5 ± 1.4 
  
2i m-CF3 73.3 ± 2.2 75.5 ± 0.5 70.8 ± 1.2 68.1 ± 0.2 66.7 ± 1.3 
2j o-CF3 90.7 ± 1.3 99.7 ± 0.6 98.2 ± 0.4 94.1 ± 0.2 92.1 ± 0.2 
2k p-OCH3 17.7 ± 1.7 21.1 ± 1.2 14.8 ± 1.5 18.4 ± 0.7 38.1 ± 0.2 
2l m-OCH3 22.6 ± 1.3 26.9 ± 0.5 23.5 ± 2.5 20.3 ± 0.6 24.1 ± 0.6 
2m o-OCH3 19.5 ± 0.3 48.1 ± 0.3 46.9 ± 0.4 41.0 ± 0.2 20.6 ± 0.4 
2n p-CH3 14.1 ± 0.6 18.6 ± 0.7 17.1 ± 0.3 20.3 ± 0.8 28.5 ± 0.5 
2o m-CH3 25.5 ± 0.8 35.2 ± 1.0 27.0 ± 0.2 20.4 ± 0.6 26.9 ± 1.7 
2p o-CH3 39.6 ± 1.4 47.1 ± 0.7 49.9 ± 0.4 44.4 ± 0.7 36.5 ± 1.6 
Table 2. Molar conversions of ammination of mono-substituted benzaldehydes 2a-p (10 mM) with transaminases (0.1 mg/mL) in phosfate buffer 
medium 50 mM pH 8, DMSO 10% as cosolvent, 1 M alanine and 0.1 mM PLP. Biotransformations were carried out for 24 h at 37°C under gently 
agitation 
 
 
 
 
Entry Substrate WT W56G  Y149F  F84A  I258A  
3a (S)-PEA 99.9 ± 0.2 99.7 ± 0.3 99.5 ± 0.5 99.6 ± 0.2 83.5 ± 1.0 
3b (S)-p-F 99.9 ± 0.1 95.4 ± 1.3 95.4 ± 0.1 47.7 ± 1.3 95.9 ± 0.4 
3c (S)-m-F 99.9 ± 0.2 95.5 ± 0.2 91.7 ± 1.4 34.8 ± 1.9 93.2 ± 2.5 
3d (S)-o-F 82.9 ± 2.0 84.6 ± 1.4 68.3 ± 1.2 12.8 ± 0.1 20.2 ± 0.1 
3e (S)-p-OCH3 99.3 ± 0.6 98.0 ± 1.0 97.9 ± 0.6 70.7 ± 0.6 98.3 ± 0.1 
3f (S)-m-OCH3 97.9 ± 1.0 94.8 ± 0.9 97.9 ± 0.3 75.3 ± 0.2 98.2 ± 0.6 
3g (S)-o-OCH3 71.7 ± 1.9 78.0 ± 1.1 46.2 ± 2.4 10.3 ± 1.0 72.1 ± 1.2 
3h (S)-p-CH3 99.7 ± 0.3 98.6 ± 1.5 97.3 ± 0.8 76.7 ± 0.6 98.4 ± 0.1 
Table 3. Molar conversions of oxidation of mono-substituted amines 3a-h (10 mM) with transaminases (0.1 mg/mL) in phosfate buffer medium 50 
mM pH 8, DMSO 10% as cosolvent, 10 mM pyruvate and 0.1 mM PLP. Biotransformations were carried out for 24 h at 37°C under gently agitation 
Interestingly, among the mutants, only W56G had better activity with the ortho-substituents (o-F- and o-OCH3-amine), while the 
other mutations showed a major destabilizing effect. The molar conversion of F84A indeed dropped to just over 10% conversion with 
both substrates in the same reaction time. This could be attributed to an impairment effect of the first step in the catalytic cycle 
where the substrate displaces the catalytic lysine from the PLP. F84 appears essential in the case of substituted aromatic amines in 
stabilising the binding of the substrate as well as assisting the catalytic mechanism. However, this effect is not observed with the 
natural substrate (S)-PEA probably due to a very efficient reaction that masks the negative impact of the mutation. These data were 
also confirmed by very different Km for o-amines with W56G and F84A compared with wild type (0.61 o-FW56G; 1.80 o-FF84A; 1.38 o-
FWT and 0.45 o-OCH3 W56G; 3.97 o-OCH3 F84A; 1.98 o-OCH3 WT expressed in mM). W56G and I258A, predicted as the best mutated 
transaminases for para-derivatives, in oxidising conditions showed very similar results with respect to wild type enzyme.  The 
mutations can effectively alter the efficiency of the enzymes in just one direction, therefore also altering the equilibrium of the 
reaction. 
Experimental 
Expression and purification of the HEWT in E. coli 
Protein expression and purification was performed following previously reported protocols.11The proteins yields after the IMAC 
purification were estimate to be: WT 100 mg, W56G 93 mg, F84A 47 mg, Y149G 32 mg, and I258A 88 mg for 1 Liter of expression 
media.  The assay derived from Schatzle, et al.20 was used as standard enzymatic assay following the procedure applied in Cerioli, et 
al.11 to assess the enzymes activity in standard conditions and evaluate then their stability (see ESI). 
HEWT mutant generation  
The SupC gene of HEWT harboured in a pRSETb plasmid was mutated using the QuikChangeXL single point mutation kit provided by 
Agilent Technologies®. The oligonucleotide primers designed exploiting the QuickChange Primer Design tool (Agilent Technologies®) 
  
were synthesised from Eurofins Genomics®. The four HEWT mutants were achieved using the following primers: W56G 5'-
cggcatggccgggcttggctgcgtgaatctc-3'; F84A 5'-ctgccgtactacaacaccgccttcaagaccacgcatcc-3'; Y149F 5'-gtcgcgagaacgcctttcacggctcca-3'; 
I258A 5'-cgccgacgaggt ggcctgcggcttcggg-3' (mutated codon is underlined). 
Ketones and aldehydes reactions  
The batch reactions to evaluate the conversion after 24 h, with wild-type and mutated HEWT, were performed in 1.5 mL micro 
centrifuge tubes; 200 µL reaction mixture in 50 mM phosphate buffer pH 8.0, containing 10 mM amino acceptor substrate dissolved 
in 10% DMSO, 1.0 M L-Alanine (amino donor substrate), 0.1 mM PLP, and 0.1 mg/mL enzyme, was left under gentile shaking at 37 
°C. 10 µL aliquots were quenched with trifluoroacetic acid (TFA) 0.2% at 24 hours and then analysed by HPLC equipped with a 
Supelcosil LC-18-T column (250 mm x 4.6 mm, 5 µm particle size; Supelco, Sigma-Aldrich, Germany). The compounds were detected 
using an UV detector at 210 nm, or 250 nm after an isocratic run with 25% acetonitrile/75% water with TFA 0.1% v/v at 25 °C with a 
flow rate of 1 mL/min. The retention times in minutes are listed in table S.1. Calibration curve for substrate and product were carried 
out with commercial standard and the conversion was then estimated, when possible, both from the substrate signal decreasing and 
product signal forming.   
Amines reactions 
The batch reactions to evaluate the conversion after 24h, with wild-type and mutated HEWT, were performed in 1.5 mL micro 
centrifuge tubes; 200 µL reaction mixture in 50 mM phosphate buffer pH 8.0, containing 10 mM amino donor substrate dissolved in 
10% DMSO, 10 mM Pyruvate (amino acceptor substrate), 0.1 mM PLP, and 0.1 mg/mL enzyme, was left under gentile shaking at 37 
°C. The conversion was evaluated by HPLC with the same procedures described above. Retention times are listed in Table S.1 in ESI. 
The kinetic profiles for the amine substrates were measured using a Bio-Tek EPOC2 microplate reader. The reaction mixture was set 
up in 300 L of activity buffer (50 mM phosphate buffer pH 8.0) containing a variable concentration of substrate amino donor (0.01 
to 2 mM), 10 mM of pyruvate, 0.1 mM PLP and an appropriate amount of enzyme. The reaction rate was detected at 245 nm over 
20 minutes at 25°C. The molar extinction coefficient was calculated for each product in order to calculate the reaction rate in mM/s 
(data not shown). The data were elaborated by fitting them with the Lineweaver–Burk double reciprocal plot which yielded the 
Michaelis-Menten parameters (Km and Kcat). 
Chirality evaluation 
To evaluate the enantioselectivity of the enzymes, the chiral amine products were assessed by chiral HPLC analysis, following 
derivatization to the corresponding amides by adapting the method reported by Andrade et al. with Codex® ATA Screening Kit. 
Addition of 100 µL 5 M NaOH to the sample was followed by extraction in 900 µL methyl-tert-butyl ether (MTBE) and then by addition 
of 5 µL triethylamine and 5 µL acetic anhydride. A normal-phase HPLC method was performed on an Agilent Technologies 1200 
equipped with a Chiralpak® IC (250mm x 4.6 mm, 5 µm particle size). Detection at 254 nm after an isocratic run 95:05 Heptane:Ethanol 
at 25 °C with a flow rate of 1 mL/min. Employing this method, product and starting materials were separated with the following 
retention times (in minutes): acetophenone (7.1), derivatized (R)-1-phenylethylamine (16.7) and (S)-1-phenylethylamine (19.1), 4-
nitroacetophenone (12.4), derivatized (R)-4-nitrophenylethylamine (22.4) and (S)-4-nitrophenylethylamine (24.2), 3-
nitroacetophenone (13.6), derivatized (R)-3-nitrophenylethylamine (23.7) and (S)-3-nitrophenylethylamine (26.7), 2-
nitroacetophenone (14.2), derivatized (R)-3-nitrophenylethylamine (24.8) and (S)-3-nitrophenylethylamine (27.1) . 
Protein modelling and structural analysis 
The protein model was build using the SWISS-MODEL Homology Modeling15 tool, superimposing the HEWT protein sequence on the 
resolved structure of the homologues amino transaminase from Cromobacterium violaceum (PDB: 4a72).14 Substrate docking was 
performed exploiting the open source tool Autodock Vina.21 The results elaboration and the structural evaluation was achieved using 
the molecular visualization system PyMOL (open source license). Sequence analysis and alignment was performed with CunSurf, 
software for multiple blast provided by BioSoft.22  
Conclusions 
Transaminase from Halomonas elongata (HEWT) showed a wide variety of catalytic abilities towards different aromatic substrates 
(ketones, aldehydes, amines). Acetophenone derivatives were poor substrates for the wild-type enzyme, since only meta- and 
para-NO2 acetophenones were reduced with molar conversions ranging from 10 to 20%. Four mutants were designed following in 
silico substrate-enzyme binding mode studies. Mutant W56G proved able to catalyse also the amination of ortho-NO2 
acetophenone, as a result of reduced interferences and facilitated substrate binding. Variants W56G and F84A, which have an 
enlarged binding pocket, showed better performances with ortho-substituted benzaldehyde derivatives, whereas I258A was the 
best mutant for para-derivatives. Since the investigated mutations involved highly conserved amino acids, these findings might 
reflect the behaviour of homologs -transaminases. Therefore, as general rule, the mutation of large pocket tryptophan with a 
smaller residue yields to an improvement in the reactivity of ortho-substituted aromatic compounds. The change of the large 
pocket isoleucine provides instead an increase in activity of para-substituted molecules. On the other hand, F84 between the two 
  
pockets was very sensible to substitution and when it was changed for smaller alanine, it gave a worst conversion of ortho and para 
aromatic amines. Consequently, this position has a fundamental role in the oxidation step of amino transaminase and it should be 
preserved in order to maintain the optimal enzyme efficiency.  
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